Kaneka Aerospace Acquires Henkel Composites Portfolio
Kaneka aims to achieve more than $200 million in sales by 2025 in high-performance composites in aerospace by fully utilizing Kaneka's global R&D resources.
Kaneka Corp. recently announced that Kaneka Aerospace LLC and Henkel Corp. have finalized the transfer of commercial rights, technologies and patents of benzoxazine-based high-performance composites business from Henkel to Kaneka Aerospace. Included in the acquisition are benzoxazine based prepregs, film adhesives, and infusion resins. Several of these products have been qualified in the aviation market.
Following the acquisition, Kaneka will reportedly continue to seek M&A and partnership opportunities for further growth. Kaneka aims to achieve more than $200 million in sales by 2025 in high performance composites in aerospace by fully utilizing Kaneka's global R&D resources.
本站所有信息與內(nèi)容，版權(quán)歸原作者所有。網(wǎng)站中部分新聞、文章來源于網(wǎng)絡(luò)或會員供稿，如讀者對作品版權(quán)有疑議，請及時與我們聯(lián)系，電話：025-85303363 QQ：2402955403。文章僅代表作者本人的觀點(diǎn)，與本網(wǎng)站立場無關(guān)。轉(zhuǎn)載本站的內(nèi)容，請務(wù)必注明"來源：林中祥膠粘劑技術(shù)信息網(wǎng)（www.423344.com）".
更多
©2015 南京愛德福信息科技有限公司 蘇ICP備10201337 | 技術(shù)支持：南京聯(lián)眾網(wǎng)絡(luò)科技有限公司
加載中...
